Washington, DC—Two bipartisan measures authored by Congressman Brian Fitzpatrick (PA-08) were signed into law today as part of a bipartisan effort to combat the opioid epidemic.
Washington, DC—The U.S. House of Representatives advanced two bipartisan measures authored by Congressman Brian Fitzpatrick (PA-08) to prevent prescription drug abuse.
Washington, DC—Congressman Brian Fitzpatrick (PA-08) today signed onto the Maintaining Protections for Patients with Pre-Existing Conditions Act of 2018 [H.R.6898], which would maintain protections for individuals with pre-existing conditions.
Currently, twenty states are filing a lawsuit in federal court arguing that the entirety of the Patient Protection and Affordable Care Act (ACA) is unconstitutional. If these suits succeed, there is a risk that patients with pre-existing conditions would be stripped of certain protections afforded by the ACA.
WASHINGTON – Congressman Brian Fitzpatrick release a statement after the House of Representatives overwhelmingly voted to repeal the Medical Device Tax.
Washington, DC – Bipartisan legislation introduced by Congressman Brian Fitzpatrick (PA-08) to combat the opioid epidemic unanimously passed the House Tuesday afternoon. The REACH OUT Act will ensure that prescribers have the necessary tools for preventing prescription drug abuse.
WASHINGTON, DC – Congressmen Brian Fitzpatrick (R-PA), Carlos Curbelo (R-FL), and Mike Thompson (D-CA) authored a bipartisan bill to help medical professionals implement best practices for prescribing opioids. Their REACH OUT Act unanimously passed the Energy and Commerce Committee and will be considered by the full House this month.
WASHINGTON, D.C. – Right to Try Legislation passed the House Tuesday evening with a bipartisan vote of 250-169. The bill – The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act [S.204], a Senate companion bill to Congressman Brian Fitzpatrick’s Right to Try legislation, follows months of legislative efforts and improves access to experimental treatments for patients with terminal illnesses. The bill now awaits the President’s signature.